Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 627

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Autopsy Findings and Venous Thromboembolism in Patients With COVID-19

Wichmann, Dominic·2020·Annals of Internal Medicine

Abstract

Letters15 December 2020Autopsy Findings and Venous Thromboembolism in Patients With COVID-19FREEDominic Wichmann, MDDominic Wichmann, MDUniversity Medical Center Hamburg-Eppendorf, Hamburg, Germany (D.W.)Author, Article, and Disclosure Informationhttps://doi.org/10.7326/L20-1206 SectionsAboutVisual AbstractPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE:Dr. Epelbaum raises concerns that focusing on VTE or PE in patients with COVID-19 may misdirect investigators' attention to an epiphenomenon. We strongly disagree, especially because we believe that the references he gives do not back up his statements.Dr. Epelbaum states that lack of VTE prophylaxis “remains a global deficiency,” citing a study by Kröger and colleagues (1). The main topic of this study was to investigate whether patients presenting with VTE/PE in Germany had a risk factor that could have been identified previously. Most of these patients had no medical condition and no identifiable risk factor. The algorithm consequently decided against prophylaxis, which can hardly be extrapolated to patients with COVID-19.It is correct that PE is a common (but rarely fatal) finding on computed tomography in critically ill patients (2), most likely because performance of this study has improved in recent years. In contrast, one third of our patients had a fatal PE. Furthermore, Dr. Epelbaum states that we used Bikdeli and associates' consensus statement to corroborate the demand for general anticoagulant treatment for patients with COVID-19 (3). This is not correct; instead, we stressed the need for further studies on this subject. The consensus statement focused largely on the effects of COVID-19–associated coagulopathies on anticoagulant strategies for cardiovascular interventions. A short paragraph cited by Dr. Epelbaum deals with empirical anticoagulant therapy in patients with COVID-19 and notes, “The majority of panel members consider prophylactic anticoagulation, although a minority consider intermediate-dose or therapeutic dose to be reasonable.” This statement was written before our study and others were published (4). The panel's decision was based mainly on a single retrospective study from China in which only laboratory abnormalities had been presented and no autopsies had been done (5). As such, our study and that by Baldi and coworkers add substantial value to the consensus statement's claim that the “optimal dosing [for anticoagulant treatment] in patients with severe COVID-19 remains unknown and warrants further prospective investigation.”References1. Kröger K, Moerchel C, Bus C, et al. Venous thromboembolism in Germany: results of the GermAn VTE registry (GATE-registry). Int J Clin Pract. 2014;68:1467-72. [PMID: 25333964] doi:10.1111/ijcp.12504 CrossrefMedlineGoogle Scholar2. Minet C, Lugosi M, Savoye PY, et al. Pulmonary embolism in mechanically ventilated patients requiring computed tomography: prevalence, risk factors, and outcome. Crit Care Med. 2012;40:3202-8. [PMID: 23164766] doi:10.1097/CCM.0b013e318265e461 CrossrefMedlineGoogle Scholar3. Bikdeli B, Madhavan MV, Jimenez D, et al; Global COVID-19 Thrombosis Collaborative Group, endorsed by the ISTH, NATF, ESVM, and the IUA, supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75:2950-73. [PMID: 32311448] doi:10.1016/j.jacc.2020.04.031 CrossrefMedlineGoogle Scholar4. Baldi E, Sechi GM, Mare C, et al; Lombardia CARe Researchers. Out-of-hospital cardiac arrest during the COVID-19 outbreak in Italy [Letter]. N Engl J Med. 2020;383:496-8. [PMID: 32348640] doi:10.1056/NEJMc2010418 CrossrefMedlineGoogle Scholar5. Tang N. Response to ‘Reply to Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy' [Letter]. J Thromb Haemost. 2020;18:1520-1. [PMID: 32302451] doi:10.1111/jth.14851 CrossrefMedlineGoogle Scholar Comments0 CommentsSign In to Submit A Comment Author, Article, and Disclosure InformationAuthors: Dominic Wichmann, MDAffiliations: University Medical Center Hamburg-Eppendorf, Hamburg, Germany (D.W.)Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M20-2003. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoAutopsy Findings and Venous Thromboembolism in Patients With COVID-19 Dominic Wichmann , Jan-Peter Sperhake , Marc Lütgehetmann , Stefan Steurer , Carolin Edler , Axel Heinemann , Fabian Heinrich , Herbert Mushumba , Inga Kniep , Ann Sophie Schröder , Christoph Burdelski , Geraldine de Heer , Axel Nierhaus , Daniel Frings , Susanne Pfefferle , Heinrich Becker , Hanns Bredereke-Wiedling , Andreas de Weerth , Hans-Richard Paschen , Sara Sheikhzadeh-E

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7326/l20-1206

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 1

  1. 10.1111/ijcp.12504 · doi:10.1111/ijcp.12504

Cited by

See all 627

Metadata

Authors
Wichmann, D.
Venue
Annals of Internal Medicine
Published
2020-12-15
Volume
173
Issue
12
Pages
1030
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W3020869775
Cited by
627
References
4
FWCI
75.96
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Autopsy Findings and Venous Thromboembolism in Patients With COVID-19. https://app.cochat.ai/papers/10.7326/l20-1206
The paper
Wichmann, D. (2020). Autopsy Findings and Venous Thromboembolism in Patients With COVID-19. Annals of Internal Medicine. https://doi.org/10.7326/l20-1206

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.